The FDA has approved Rapiblyk, a new drug to treat irregular heartbeats in critically ill hospitalized patients with severe ...

Atrial flutter and fibrillation are especially ... are designated as paroxysmal supraventricular tachycardia, and are most frequently due to atrioventricular re-entry tachycardia (AVRT) or ...

AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration ...

The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia.